Caregiver Employer: A Winning Risk Team's take on COVID-19

“From the beginning, our intention was to continue our mission of advocacy for our employees,” says Joseph F. Molloy, vice president of Workforce Safety at Northwell Health, the largest private employer in New York State and a 2019 winner of NU Property & Casualty’s Excellence in Workers’ Compensation Risk Management Award.

June 24, 2020 /PRNewswire/ —Frontline work battling the novel coronavirus is tough, but imagine having to deal with the COVID-19 crisis as both an employer and a health care provider.

That’s been the work this year of such companies as Northwell Health, the largest health care provider and private employer in New York State, and one of the winners of NU Property & Casualty’s 2019 Excellence in Workers’ Compensation Risk Management Award. (Click here for details about the 2020 awards program; nominations are being accepted through June 30).
We recently connected with Joseph Molloy, vice president of workforce safety at Northwell Health, to hear more about how the company has fared during the pandemic.

PC360: How has Northwell Health risen to the challenge of managing workers’ compensation risk in 2020?
Molloy: 2020 has presented some extraordinary challenges for the Workforce Safety Team at Northwell Health. As the largest private employer in New York with 77,000 employees, managing safety and workers’ compensation is a herculean task.

Northwell Health has treated more COVID-19 patients than any other hospital system in the country. As guidance from the state health department as well as the Centers for Disease Control and Prevention changed on nearly an hourly basis, we had to be nimble and responsive. We had thousands of employees exposed. Many were put on 14-day self-quarantine furloughs. Some converted and contracted the illness.

From the beginning, our intention was to continue our mission of advocacy for our employees, making the assumption going in that anyone who did contract the disease did so as a result of work. This was a bold step as community exposures were rampant, but key in showing our support for our employees who were on the front lines.
We have been recording and investigating more than 4,400 (at last count) incidents related to COVID-19, complicated because some were reported to Workforce Safety, some through HR, and some through our Employee Health Services.

Further, we did have fatalities. The Occupational Safety and Health Administration (OSHA) was overwhelmed with the volume, and some of our cases were handled in remote locations, complicating the investigation and resolution.

PC360: Are there any particular tools that helped Northwell Health manage the crisis?

Molloy: We implemented Xybion’s Emidence platform, which has been key in ensuring rapid and appropriate response. Northwell, as an organization, stood behind all of our employees, especially those exposed. Workforce Safety has been working 7 days a week since the beginning of March. While this was going on, some of the Workforce Safety team was redeployed to help care for the COVID-19 patients, putting an additional burden on the remaining members of the team. I couldn’t be more proud of the dedication and efforts of the entire team.

PC360: What are likely to be the key workers’ comp risk management lessons and/or takeaways from this year?

Molloy: Key lessons learned are definitely centered around exposures.

While Northwell was well-prepared (as a health care provider, we have exposures to things like flu, measles, mumps, rubella, TB, Ebola and now COVID-19,) many colleagues at other companies reached out for suggestions on how we were handling claims (both the surge and the relation to exposure). Reviewing contracts for direct and secondary risk, reinforcing communication and operations with your TPA, and establishing appropriate emergency preparedness are critical in the “new normal” operations arena.

Moreover, with so many employees working remotely, it’s important to ensure that you have appropriate policies and procedures to handle remote operations and at-home risks. To conclude, being prepared, maintaining flexibility, and communicating to your organization are critical to successfully administering worker’s comp in this environment.

Share the Article

Share on linkedin
Share on facebook
Share on twitter
Share on pinterest
Share on reddit
Share on whatsapp
Share on email
stock market background

Contact Investor Relations and Sign Up for Newsletters

stock market background

Contact Investor Relations and Sign Up for Newsletters

Heidi Krueger

Head of Quality Assurance

Heidi leads Xybion’s Quality Assurance practice. She has over 20 years’ experience in designing and implementing quality assurance policies. Since joining Xybion in 2000, Heidi worked with several clients to design quality policies and ensure compliance. She is responsible to hosting Xybion customer audits. Heidi has a BA degree in Biology from The King’s College.

James Castonguay

Product Technology Lead

James provides leadership to Xybion quality management systems including product design, development and client delivery. James started working with Xybion in 2002 in its Canadian division. He is now managing product delivery from the United States. James has a master’s degree in mathematics and minor in informatics from the University of Sherbrook, Quebec, Canada.

Dave Chiaramonte

Enterprise Assets and HSE Leader
Dave brings diverse and deep expertise to his leadership role as the leader of Enterprise Asset Management (EAM) and Employee Health & Safety line of business. Dave has over twenty years of experience within the Information Technology industry including development, implementation and integration of complex Enterprise Systems in large corporate environments. He is a highly regarded technology leader in IBM’s Maximo Asset Management Product implementation. Dave worked with BMS and Dupont pharmaceuticals before joining Xybion in 2004.

Tom Klapmuts

Digital Lab Solution Leader

Tom provides leadership in design, delivery and revenue growth of Xybion digital lab solutions. He is an experienced client solutions manager with a demonstrated history of working with many clients globally to solve their business problems. Tom has training in U.S. Food and Drug Administration (FDA), Good Laboratory Practice (GLP), Life Sciences, CRO Management, and Clinical Development. Before joining Xybion, Tom worked for pharmaceutical companies such as Merck and Schering Plough. Tom is a Purdue university alumnus.

Priya Rajesh

Head of Sales: APAC & EMEA

Priya is responsible for Xybion business growth in APAC and EMEA region. She brings over 18 years of experience in Business Consulting and Operations Management. Her deep expertise in diversified areas, including strategic alliance and partnership management, diversity and inclusivity initiatives and employee development, will amplify Xybion’s global strategic relationships and will strengthen the company’s executive leadership in India. In her last role at Conduent, she served as Director-Marketing & Bid Management. Prior to this, Priya has worked with Infosys and Covansys (now CSC). Priya holds degrees in microbiology & health management.

Raji Bijur

Head of Quality Control & CSV

Raji leads Xybion Quality Control function. She has over 22 years of experience in software quality management, CSV, SQA, software process & KPI development and industry benchmarking. She has strong process implementation knowledge including ISO, CMMI, Agile, Scrum, Six Sigma, Lean. Certified CSQA, CSV, GCP, and GAMP. Raji has led implementation of QC processes in Robotic Process Automation (RPA) projects. Before coming to Xybion in 2019, she worked with IQVIA (Former Quintiles), Infosys, Aris Global, Mphasis and serving clients across different market segments. Raji has a bachelor’s degree in information science & technology and MBA from Indian Institute of Management, Ahmedabad.

Bob Friedman

Chief Solution Architect

Bob Friedman has over 25 years of experience in Preclinical information systems at Xybion Corporation as a developer, development manager and Chief Solution Architect. He has been an active member of the CDISC SEND standards consortium for five years as well as the PhUSE / FDA Industry Collaboration. Bob has previously worked for Synthes Orthopedics, NYU Medical Center and the New York State Department of Health. He has a master’s degree in Biomedical Engineering from Rensselaer Polytechnic Institute.

Gokul Panda

Head of Platform and Product Development

Gokul is the Head of Platform and Product Development, responsible for developing new and critical platforms and products. He has over 20 years of enterprise software development in the life sciences industry and related fields. Gokul holds both a Bachelor’s Degree and Master’s Degree in Engineering from the Indian Institute of Engineering, Science, and Technology. Gokul’s unrivaled expertise in enterprise software architecture and solutions provides Xybion’s clients with leading product functionality, innovation, and platform stability.

Anu Roy

Chief Solutions Delivery Officer

Anu manages project delivery and relationship. She has over 18 years of Life Sciences industry and IT services experience. Anu has a strong track record of designing and developing digital solutions, management consulting, quality & compliance Management, CLM, process & key metrics design, program execution & improvement and account management. Anu is a recipient of the STEM WOC ‘Technology Rising Star ‘by US Women’s magazine in 2014. She has received several other awards including Infosys Consulting Architect Award for outstanding achievement in 2011, RCL Crown Golden Brain Award in 2013. Anu is a guest columnist at Pharmaceutical Compliance Monitor and published in several international business magazines. Anu has a bachelor’s degree in Biochemistry and MBA in marketing.

Keith Dempsey

Chief Information Officer

Keith Dempsey has joined Xybion as our global CIO. He brings 20+ years of progressive Information Technology experience from Merck, AIG, Barclays and PriceWaterhouse. Focusing his career on building global strategies that capitalize on progressive technologies that scale in accordance to realized business growth. His experiences range from introducing new technologies that facilitated a competitive advantage for Merck, introduced new and scalable technologies for AIG Investments, and created progressive global organizational improvements for Barclay’s Capital. Keith has a degree in Chemical Engineering from Clarkson University and an MBA from William Paterson University.

Steve Porfano

Executive Vice President & Chief Financial Officer

Steve manages Xybion corporate function which includes Finance, HR, Legal and QA. Steve joined Xybion in 1989 as Corporate Controller and was promoted to Chief Financial Officer in 1991. As Chief Financial Officer, Steve is responsible for the establishment, enhancement, coordination and administration of the Company’s financial systems, internal controls, and related areas. Additionally, he is the corporate liaison to the Company’s bank, independent certified public accounting firm and governmental compliance and financial auditors.

Kamal Biswas

President & Chief Operating Officer

Kamal joined Xybion as its President and Chief Operating Officer in 2018. He is an acknowledged leader in the life sciences industry and has over 20 years’ experience in management consulting and pharmaceutical business. Very recently, Kamal was a Partner and leader of the global Life Sciences practice at Infosys Consulting. Before that, he spent several years working with pharma companies including Novartis Pharma and Ciba Geigy to manage manufacturing and late-stage R&D functions.

Pradip K. Banerjee, Ph.D., MBA

Chairman of the Board & Chief Executive Officer

Dr. Banerjee is an entrepreneurial senior executive with 30+ years of in-depth experience in the global Life Sciences, Healthcare and Services industry in global operations, strategic management, business development, investments and new ventures creation, M&A and Buy-outs. Prior to acquiring Xybion in 2008, Pradip served as President and CEO of Science Center in Philadelphia focused on creating, incubating, managing and investing in science based new companies. He was the Partner-in-Charge of the pharmaceutical Research & Development unit of Accenture where he created the R&D consulting unit and had grown it to become $100+ million worldwide business. Dr. Banerjee holds a Ph.D. in Pharmaceutical Sciences from University of Wisconsin-Madison and an MBA from the Wharton Business School of University of Pennsylvania.

Employee Name

Job Title

Job Description